---
title: "BridgeBio Pharma 美股盤前漲超 10%"
description: "BridgeBio Pharma 美股盤前漲超 10%，現報 59.96 美元。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/262876461.md"
published_at: "2025-10-27T11:06:23.000Z"
---

# BridgeBio Pharma 美股盤前漲超 10%

> BridgeBio Pharma 美股盤前漲超 10%，現報 59.96 美元。

BridgeBio Pharma 美股盤前漲超 10%，現報 59.96 美元。

### Related Stocks

- [BBIO.US - Bridgebio Pharma](https://longbridge.com/zh-HK/quote/BBIO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| BridgeBio Pharma Highlights Attruby Surge, Preannounces $146M Q4 Revenue at JPM Healthcare Conference | BridgeBio Pharma (NASDAQ:BBIO) presented at the J.P. Morgan Healthcare Conference, highlighting its ATTR-CM product, Att | [Link](https://longbridge.com/zh-HK/news/272361328.md) |
| BridgeBio Pharma (BBIO) Valuation Check After Insider Selling And Upcoming Infigratinib Trial Updates | BridgeBio Pharma (BBIO) faces scrutiny as insider selling coincides with upcoming catalysts, including a January 9 webin | [Link](https://longbridge.com/zh-HK/news/271695155.md) |
| BridgeBio Pharma Highlights Pipeline Progress and Patient Impact in New Corporate Presentation | BridgeBio Pharma Inc. has released a corporate presentation outlining its pipeline and strategy, focusing on first-in-cl | [Link](https://longbridge.com/zh-HK/news/272295165.md) |
| BridgeBio Pharma Insider Sold Shares Worth $2,239,902, According to a Recent SEC Filing | BridgeBio Pharma Insider Sold Shares Worth $2,239,902, According to a Recent SEC Filing | [Link](https://longbridge.com/zh-HK/news/269985479.md) |
| BridgeBio Pharma Director Ronald J. Daniels Reports Disposal of Common Shares | Ronald J. Daniels, Director at BridgeBio Pharma Inc., has reported the disposal of common shares of the company. The ful | [Link](https://longbridge.com/zh-HK/news/264939214.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。